Synsight was a company created in 2013, by two co-founders PhD Computer aided drug design: Cyril Bauvais (CEO) and Guillaume Bollot (CSO). In july 2024, Synsight was acquired by @iktos, an AI drug discovery company.
Its tech is based on AI drug design and cell imaging, including a proprietary cell based assay named MTBench, to profile compounds modulators of protein-protein and protein-RNA interactions, and protein agregation.
Company Details
- Employees
- 1
- Founded
- -
- Address
- 4, Rue Pierre Fontaine, Genopole Entreprises,france
- Phone
- (+33) 01 69 47 01 76
- in****@****ght.net
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- synsight.net
- Keywords
- criblage virtuel, modélisation moléculaire, dynamique moléculaire, QSAR, drug design, chémoinformatique, drug discovery.
- HQ
- Évry, Ile-de-France
Synsight Questions
Synsight's helpline number is (+33) 01 69 47 01 76
Synsight's website is synsight.net
Synsight's LinkedIn profile is https://de.linkedin.com/company/synsight
Synsight has
1 employees.
View email and phone details for 1
employees at Synsight.
Synsight's industry is
Pharmaceutical Manufacturing
Synsight's top competitors are
Clario,
Ariana Pharma,
Owkin,
Qubit Pharmaceuticals,
Stemselect,
Valerio Therapeutics,
Atomwise,
Exscientia,
Aqemia,
Iktos.
Synsight's support email address is info@synsight.net
Synsight's categories are Pharmaceutical Manufacturing
Synsight's founding year is 2013
